Neuren Pharmaceuticals | NEU - Selling And Administration Expenses

Stock Price
12.60
Daily Change
-0.47 -3.60%
Monthly
-27.38%
Yearly
-8.76%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD1.24M in Selling and Administration Expenses for its fiscal semester ending in June of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 25.74M 1.93M Mar/2025
Alaunos Therapeutics USD 585K 260K Sep/2025
Avita Medical AUD 20.98M 253K Jun/2025
Clinuvel Pharmaceuticals AUD 9.12M 6.2M Jun/2025
Dianthus Therapeutics USD 8.2M 669K Sep/2025
Genetic Signatures AUD 10.52M 1.03M Dec/2024
Ionis Pharmaceuticals USD 86.56M 4.04M Sep/2025
Medical Developments International AUD 7.03M 5.91M Jun/2025
Neuren Pharmaceuticals AUD 1.24M 1.09M Jun/2025
Organon & Co USD 399M 54M Sep/2025
Paradigm Biopharmaceuticals AUD 1.61M 747.79K Jun/2025
PYC Therapeutics AUD 2.13M 447.24K Jun/2025
Starpharma Holdings AUD 1.56M 1.57M Jun/2025
Tectonic Therapeutic USD 4.96M 190K Sep/2025
Telix Pharmaceuticals AUD 93.48M 1.04M Dec/2025
Viatris USD 886.6M 42.1M Sep/2025
Xeris Pharmaceuticals USD 46.46M 2.07M Sep/2025